← Leaderboards
Andrew L Gilman
Children'S Mercy Hosp (Kansas City, Mo)
$2,092,507
Attributed
$2,092,507
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$2,092,507 · 1
By mechanism
R01$2,092,507 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Prednisone”
- Gregory H Reaman · National Childhood Cancer Foundation$17,052,970
- Peter Scott Heeger · Case Western Reserve University$12,375,090
- Gary R Cutter · Amc Cancer Research Center$11,682,459
- Keri, Hammel · The Emmes Company, Llc$11,064,901
- Peter W Nickerson · University Of Manitoba$8,299,490
- Sharon B. Murphy · Northwestern University$7,718,936
Research focus
PrednisoneChloroquineClinical ResearchImmunopathology ChemotherapyBone Marrow TransplantationCombination ChemotherapyCooperative StudyCyclosporinesDrug Screening /EvaluationGraft Versus Host DiseaseHomologous TransplantationHormone TherapyHuman SubjectHuman Therapy EvaluationClinical Trial Phase IiiPatient Oriented Research
Grant awards (5)
HYDROXYCHLOROQUINE THERAPY AND BIOLOGY OF GVHD$438,002
R01 · FY2004 · CA
HYDROXYCHLOROQUINE THERAPY AND BIOLOGY OF GVHD$387,168
R01 · FY2003 · CA
HYDROXYCHLOROQUINE THERAPY AND BIOLOGY OF GVHD$455,489
R01 · FY2002 · CA
HYDROXYCHLOROQUINE THERAPY AND BIOLOGY OF GVHD$397,082
R01 · FY2001 · CA
HYDROXYCHLOROQUINE THERAPY AND BIOLOGY OF GVHD$414,766
R01 · FY2000 · CA